Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia.

Shovlin CL, Millar CM, Droege F, Kjeldsen A, Manfredi G, Suppressa P, Ugolini S, Coote N, Fialla AD, Geisthoff U, Lenato GM, Mager HJ, Pagella F, Post MC, SabbĂ  C, Sure U, Torring PM, Dupuis-Girod S, Buscarini E; VASCERN-HHT.

Orphanet J Rare Dis. 2019 Aug 28;14(1):210. doi: 10.1186/s13023-019-1179-1.

2.

Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia.

Buscarini E, Botella LM, Geisthoff U, Kjeldsen AD, Mager HJ, Pagella F, Suppressa P, Zarrabeitia R, Dupuis-Girod S, Shovlin CL; VASCERN-HHT.

Orphanet J Rare Dis. 2019 Feb 4;14(1):28. doi: 10.1186/s13023-018-0982-4.

3.

Prevention of serious infections in hereditary hemorrhagic telangiectasia: roles for prophylactic antibiotics, the pulmonary capillaries-but not vaccination.

Shovlin C, Bamford K, SabbĂ  C, Mager HJ, Kjeldsen A, Droege F, Buscarini E, Dupuis-Girod S; VASCERN HHT.

Haematologica. 2019 Feb;104(2):e85-e86. doi: 10.3324/haematol.2018.209791. No abstract available.

4.

European Reference Network For Rare Vascular Diseases (VASCERN) Outcome Measures For Hereditary Haemorrhagic Telangiectasia (HHT).

Shovlin CL, Buscarini E, Kjeldsen AD, Mager HJ, Sabba C, Droege F, Geisthoff U, Ugolini S, Dupuis-Girod S.

Orphanet J Rare Dis. 2018 Aug 15;13(1):136. doi: 10.1186/s13023-018-0850-2.

5.

Systematic screening in hereditary hemorrhagic telangiectasia: a review.

Kroon S, Snijder RJ, Faughnan ME, Mager HJ.

Curr Opin Pulm Med. 2018 May;24(3):260-268. doi: 10.1097/MCP.0000000000000472. Review.

PMID:
29470256
6.

A potentially hazardous object with benign appearance at the outset.

Weijs B, de Booij M, Mager HJ, Vos JA, Bootsma GP.

Neth J Med. 2015 Aug;73(7):348-50. No abstract available.

7.

Rerouting anomalous hepatic venous connection to the left atrium.

Kloppenburg GT, Post MC, Mager HJ, Schepens MA.

Ann Thorac Surg. 2010 Aug;90(2):638-40. doi: 10.1016/j.athoracsur.2010.01.080.

PMID:
20667368
8.

Genotype-phenotype relationship for localization and age distribution of telangiectases in hereditary hemorrhagic telangiectasia.

Letteboer TG, Mager HJ, Snijder RJ, Lindhout D, Ploos van Amstel HK, Zanen P, Westermann KJ.

Am J Med Genet A. 2008 Nov 1;146A(21):2733-9. doi: 10.1002/ajmg.a.32243.

PMID:
18831062
9.

Systemic inflammation in COPD visualised by gene profiling in peripheral blood neutrophils.

Oudijk EJ, Nijhuis EH, Zwank MD, van de Graaf EA, Mager HJ, Coffer PJ, Lammers JW, Koenderman L.

Thorax. 2005 Jul;60(7):538-44.

10.

Distribution of talc suspension during treatment of malignant pleural effusion with talc pleurodesis.

Mager HJ, Maesen B, Verzijlbergen F, Schramel F.

Lung Cancer. 2002 Apr;36(1):77-81.

PMID:
11891037
11.

Early cerebral infarction after embolotherapy of a pulmonary arteriovenous malformation.

Mager HJ, Overtoom TT, Mauser HW, Westermann KJ.

J Vasc Interv Radiol. 2001 Jan;12(1):122-3. No abstract available.

PMID:
11200347

Supplemental Content

Loading ...
Support Center